文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

健康系统中脓毒症照护质量改进项目的患者结局与成本效益

Patient Outcomes and Cost-Effectiveness of a Sepsis Care Quality Improvement Program in a Health System.
PubMed 文献 · Crit Care Med · 2019-01-01
一句话结论单中心观察性研究显示,实施脓毒症集束化质量改进项目后,疑似感染患者院内死亡风险降低(OR 0.70),出院更快(HR 1.25),且项目节省成本。

该单中心观察性研究纳入2014年3月1日至2017年7月31日期间13,877例疑似感染成人,比较强制报告脓毒症集束化指标生效日期前后各18个月的患者结局与成本效益。干预包括多学科脓毒症委员会、教育运动、电子健康记录工具和改良早期预警系统。多变量分析显示,实施后疑似感染患者院内死亡OR为0.70(95%CI 0.57-0.86),出院时间HR为1.25(95%CI 1.20-1.29),项目在疑似感染患者中节省成本(-$272,645.7;95%CI -$757,970.3至-$79,667.7),符合Sepsis-3标准亚组也观察到死亡 odds 降低、出院加快及成本节省。作者认为该单中心干预模型可作为住院疑似感染患者的实践基准。

要点

  • 实施脓毒症质量改进项目后,疑似感染患者院内死亡OR为0.70(95%CI 0.57-0.86),出院时间HR为1.25(95%CI 1.20-1.29)。
  • 符合Sepsis-3标准的亚组同样观察到院内死亡 odds 降低和出院速度加快。
  • 项目在疑似感染患者中节省成本(-$272,645.7;95%CI -$757,970.3至-$79,667.7),Sepsis-3组也观察到成本节省。
  • 干预措施包括多学科脓毒症委员会、教育运动、电子健康记录工具和改良早期预警系统。
  • 作者认为该单中心干预模型可作为住院疑似感染患者的实践基准。

适用人群与场景

  • 2014年3月1日至2017年7月31日期间在某单中心就诊的13,877例疑似感染成人。
  • 研究比较强制报告脓毒症集束化指标生效日期前后各18个月收治的患者。
  • 通过电子健康记录中的序贯器官衰竭评估评分、培养和抗生素医嘱识别符合Sepsis-3标准的患者。

诊断标准与关键阈值

  • 使用序贯器官衰竭评估评分、培养和抗生素医嘱从电子健康记录中识别符合Sepsis-3标准的患者。

处置流程与药物剂量

  • 实施多学科脓毒症委员会,配备脓毒症协调员和数据提取员。
  • 开展教育运动。
  • 部署电子健康记录工具。
  • 使用改良早期预警系统。

研究设计与关键结果

  • 研究为单中心观察性研究,纳入13,877例疑似感染成人,比较脓毒症集束化强制报告生效日期前后各18个月。
  • 多变量分析显示,实施后 versus 实施前疑似感染患者院内死亡OR为0.70(95%CI 0.57-0.86)。
  • 实施后 versus 实施前疑似感染患者出院时间HR为1.25(95%CI 1.20-1.29)。
  • 符合Sepsis-3标准亚组同样观察到院内死亡 odds 降低和出院速度加快。
  • 项目在疑似感染患者中节省成本(-$272,645.7;95%CI -$757,970.3至-$79,667.7),Sepsis-3组也观察到成本节省。
  • 增量成本效益比基于5,000次 bootstrap 样本估计经验95%CI。

证据类型、等级与局限

  • 证据类型:单中心观察性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,旨在遵循脓毒症集束化指标的健康系统项目可在远超符合 Centers for Medicare and Medicaid Services 测量队列的更大覆盖人群中,以成本效益方式降低死亡率和住院时间。
  • 作者认为,该单中心干预模型可作为住院疑似感染患者的实践基准。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Assess patient outcomes in patients with suspected infection and the cost-effectiveness of implementing a quality improvement program.

DESIGN, SETTING, AND PARTICIPANTS: We conducted an observational single-center study of 13,877 adults with suspected infection between March 1, 2014, and July 31, 2017. The 18-month period before and after the effective date for mandated reporting of the sepsis bundle was examined. The Sequential Organ Failure Assessment score and culture and antibiotic orders were used to identify patients meeting Sepsis-3 criteria from the electronic health record.

INTERVENTIONS: The following interventions were performed as follows: 1) multidisciplinary sepsis committee with sepsis coordinator and data abstractor; 2) education campaign; 3) electronic health record tools; and 4) a Modified Early Warning System.

MAIN OUTCOMES AND MEASURES: Primary health outcomes were in-hospital death and length of stay. The incremental cost-effectiveness ratio was calculated and the empirical 95% CI for the incremental cost-effectiveness ratio was estimated from 5,000 bootstrap samples.

RESULTS: In multivariable analysis, the odds ratio for in-hospital death in the post- versus pre-implementation periods was 0.70 (95% CI, 0.57-0.86) in those with suspected infection, and the hazard ratio for time to discharge was 1.25 (95% CI, 1.20-1.29). Similarly, a decrease in the odds for in-hospital death and an increase in the speed to discharge was observed for the subset that met Sepsis-3 criteria. The program was cost saving in patients with suspected infection (-$272,645.7; 95% CI, -$757,970.3 to -$79,667.7). Cost savings were also observed in the Sepsis-3 group.

CONCLUSIONS AND RELEVANCE: Our health system's program designed to adhere to the sepsis bundle metrics led to decreased mortality and length of stay in a cost-effective manner in a much larger catchment than just the cohort meeting the Centers for Medicare and Medicaid Services measures. Our single-center model of interventions may serve as a practice-based benchmark for hospitalized patients with suspected infection.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Afshar M, Arain E, Ye C, et al. Patient Outcomes and Cost-Effectiveness of a Sepsis Care Quality Improvement Program in a Health System. Crit Care Med. 2019. PMID: 31306176. doi:10.1097/CCM.0000000000003919

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。